BioSpace News Archive

Phagenesis Ltd, a private healthcare company offering an innovative treatment for dysphagia, announces successful treatment of intubation–induced severe neurogenic post–extubation dysphagia using pharyngeal electrical stimulation in a COVID–19 patient.

Gold Standard Diagnostics announced it offers a new B. burgdorferi VlsE-OspC IgG/IgM recombinant ELISA Screen that can be used to improve workflow and conserve testing resources.

Ra Medical Systems, Inc., a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces an increase in enrollment in its pivotal clinical trial to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy device for the treatment of peripheral arterial disease.

Aesthetic Medical International Holdings Group Limited, a leading provider of aesthetic medical services in China, announces its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2020.

TSC causes epilepsy in up to 85% of patients, and up to 60% of those patients do not respond to standard anti-epileptic medicines

Illumina, Inc., announced that it disagrees with the European Commission’s Directorate-General for Competition’s decision to review Illumina’s acquisition of GRAIL, a company founded to accelerate early screening of cancer.

Company continues its commitment to expanding health care access through its long-standing support of UNICEF USA and their efforts to eliminate Maternal and Neonatal Tetanus

Sutro Biopharma, Inc., a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, announced the promotion of Chief Scientific Officer Trevor Hallam, Ph.D., to President of Research.

Medifast, Inc . (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTA VIA® , will announce financial results for the first quarter ended March 31, 2021 on Tuesday, May 4, 2021 , after market close.

Baebies, a growth-stage company developing innovative products to enable early disease detection and comprehensive diagnosis, announced that CARB-X has awarded the company up to $11.6 million in non-dilutive funding.